Ameritas Investment Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,220
Closed -$376K 3116
2017
Q1
$376K Sell
4,220
-194
-4% -$16K 0.02% 820
2016
Q4
$312K Hold
4,414
0.02% 859
2016
Q3
$349K Buy
4,414
+724
+20% +$61.8K 0.02% 820
2016
Q2
$335K Buy
3,690
+187
+5% +$15.8K 0.02% 784
2016
Q1
$298K Sell
3,503
-225
-6% -$16.7K 0.02% 806
2015
Q4
$294K Hold
3,728
0.02% 807
2015
Q3
$262K Hold
3,728
0.02% 820
2015
Q2
$336K Hold
3,728
0.02% 770
2015
Q1
$375K Hold
3,728
0.02% 735
2014
Q4
$375K Hold
3,728
0.03% 735
2014
Q3
$359K Sell
3,728
-257
-6% -$24.4K 0.03% 719
2014
Q2
$371K Hold
3,985
0.03% 741
2014
Q1
$331K Sell
3,985
-321
-7% -$26K 0.03% 756
2013
Q4
$361K Hold
4,306
0.03% 726
2013
Q3
$320K Buy
+4,306
New +$323K 0.03% 716

Other funds holding MJN

Ameritas Investment Partners's MJN Position: Q2 2017 in Review

Ameritas Investment Partners sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 4,220 shares — an estimated $376K sold.

Ameritas Investment Partners first reported a position in MJN in Q3 2013 and held it in 15 quarters. The position peaked at $376K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Ameritas Investment Partners reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,220 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $376K.
  • Ameritas Investment Partners first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 15 quarters.
  • Ameritas Investment Partners's Mead Johnson Nutrition Company position peaked at $376K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Ameritas Investment Partners's 13F filing for Q2 2017, filed 15 Aug 2017.